AH
Assort HealthAssort Health builds AI voice agents that automate patient access workflows for healthcare organizations, including scheduling, intake, referrals, and insurance verification.
2 Pulse stories
ST
Scribe TherapeuticsClinical-stage biotech developing CRISPR-based gene-editing therapeutics using its proprietary CasX enzyme platform.
5 Pulse stories
Total Raised
$222M
Assort HealthScribe Therapeutics
Last Valuation
$1.2B
Assort HealthScribe Therapeutics
Biotech
Sector
Biotech
2023
Founded
2018
San Francisco, California
HQ
Alameda, California
Private
Status
Public (SCTX)
Assort Health investors
Menlo VenturesLightspeed Venture PartnersFelicisFirst Round CapitalChemistryLiquid 2 VenturesQuiet CapitalA* Capital
Scribe Therapeutics investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Assort Health and Scribe Therapeutics.